-(ar)abine
Nucleosides built on an arabinose sugar.
- Drugs ending in -(ar)abine: 14
- Approved somewhere: 7
- With a US drug page: 8
- Stem
- -(ar)abine
- Class
- Nucleosides built on an arabinose sugar
- Sub-stems
- -abine
- Most common targets
- DNA (5), DNA polymerase (alpha/delta/epsilon) (4), RNA (3), Ribonucleoside-diphosphate reductase RR1 (2), KCNQ (Kv7) potassium channel (1), SLC6A1 (1), DNA polymerase catalytic subunit (1), CNR1 (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -(ar)abine or one of its sub-stems, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Clofarabine | Approved | Ribonucleoside-diphosphate reductase RR1, DNA, DNA polymerase (alpha/delta/epsilon) | Ribonucleoside-diphosphate reductase RR1 inhibitor |
| Cytarabine | Approved | DNA, RNA, DNA polymerase (alpha/delta/epsilon) | DNA inhibitor |
| Ezogabine | Approved | KCNQ (Kv7) potassium channel | KCNQ (Kv7) potassium channel opener |
| Fludarabine phosphate | Approved | Ribonucleoside-diphosphate reductase RR1, DNA polymerase (alpha/delta/epsilon) | Ribonucleoside-diphosphate reductase RR1 inhibitor |
| Nelarabine | Approved | DNA | DNA inhibitor |
| Tiagabine | Approved | SLC6A1 | GABA transporter 1 inhibitor |
| Vidarabine | Approved | DNA polymerase catalytic subunit | Human herpesvirus 1 DNA polymerase inhibitor |
| Fludarabine | Phase 3 | — | — |
| Cytarabine 5'-phosphate | Phase 3 | — | — |
| Elacytarabine | Phase 3 | DNA, RNA | DNA inhibitor |
| Aspacytarabine | Phase 2 | DNA, RNA, DNA polymerase (alpha/delta/epsilon) | DNA disrupting agent |
| Pivagabine | Phase 2 | — | — |
| Thiarabine | Phase 1 | — | — |
| Nonabine | — | CNR1, CNR2 | Cannabinoid CB1 receptor agonist |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO